Ocular Complications of Systemic Medications

Chang, 2005, Intraoperative floppy iris syndrome associated with tamsulosin, J Cataract Refract Surg, 31, 664, 10.1016/j.jcrs.2005.02.027 Herd, 2007, Intraoperative floppy-iris syndrome with doxazosin, J Cataract Refract Surg, 33, 562, 10.1016/j.jcrs.2006.11.019 Yeu, 2007, Saw palmetto and intraoperative floppy-iris syndrome, J Cataract Refract Surg, 33, 927, 10.1016/j.jcrs.2006.12.032 Chang, 2007, A prospective multi-center evaluation of cataract surgery in patients taking tamsulosin (Flomax), Ophthalmology, 114, 957, 10.1016/j.ophtha.2007.01.011 Blouin, 2007, Intraoperative floppy-iris syndrome associated with alpha1-adrenoreceptor: comparison of tamsulosin and alfuzosin, J Cataract Refract Surg, 33, 1227, 10.1016/j.jcrs.2007.03.032 Friedman, 2009, Tamsulosin and the intraoperative floppy iris syndrome, JAMA, 301, 2044, 10.1001/jama.2009.704 Flach, 2009, Intraoperative floppy iris syndrome: pathophysiology, prevention, and treatment, Trans Am Ophthalmol Soc, 107, 234 Laties, 1999, Ocular safety of Viagra, (sildenafil citrate), Trans Am Ophthalmol Soc, 97, 115 Borillo, 1998, Dangers of Viagra use in pilots: AMEs should become familiar with the detrimental side-effects of sildenafil, Federal Air Surgeons Med Bull Fall Pomeranz, 2002, Sildenafil-associated nonarteritic anterior ischemic optic neuropathy, Ophthalmology, 109, 584, 10.1016/S0161-6420(01)00976-9 Fraunfelder, 2006, Nonarteritic anterior ischemic optic neuropathy and sildenafil, Arch Ophthalmol, 124, 733, 10.1001/archopht.124.5.733 Fraunfelder, 2004, Topiramate-associated acute, bilateral, secondary angle-closure glaucoma, Ophthalmology, 111, 109, 10.1016/j.ophtha.2003.04.004 Banta, 2001, Presumed topiramate-induced bilateral acute angle-closure glaucoma, Am J Ophthalmol, 132, 112, 10.1016/S0002-9394(01)01013-3 Rhee, 2001, Bilateral angle-closure glaucoma and ciliary body swelling from topiramate, Arch Ophthalmol, 119, 1721 Fraunfelder, 2004, Adverse ocular drug reactions recently identified by the National Registry of Drug-Induced Ocular Side Effects, Ophthalmology, 111, 1275, 10.1016/j.ophtha.2003.12.052 Mustafa, 1995, Diversity of GABA receptors in the vertebrate outer retina, Trends Neurosci, 18, 118, 10.1016/0166-2236(95)93886-3 Willmore, 2009, Vigabatrin: 2008 update, Epilepsia, 50, 163, 10.1111/j.1528-1167.2008.01988.x Krauss, 2009, Evaluating risk for vigabatrin treatment, Epilepsy Currents, 9, 125, 10.1111/j.1535-7511.2009.01315.x Buncic, 2004, Characteristic retinal atrophy with secondary “inverse” optic atrophy identifies vigabatrin toxicity in children, Ophthalmology, 111, 1935, 10.1016/j.ophtha.2004.03.036 Imperia, 1989, Ocular complications of systemic cancer chemotherapy, Surv Ophthalmol, 34, 209, 10.1016/0039-6257(89)90105-7 Burns, 1992, Ocular toxicities of chemotherapy, Semin Oncol, 19, 492 Al-Tweigeri, 1996, Ocular toxicity and cancer chemotherapy. A review, Cancer, 78, 1359, 10.1002/(SICI)1097-0142(19961001)78:7<1359::AID-CNCR1>3.0.CO;2-G Schmi, 2006, Update on ocular complications of systemic cancer chemotherapy, Surv Ophthalmol, 51, 19, 10.1016/j.survophthal.2005.11.001 Kapp, 1985, Supraophthalmic carotid infusion for recurrent glioma, J Neurooncol, 3, 5, 10.1007/BF00165165 Brink, 1995, Punctal and canalicular stenosis associated with systemic fluorouracil therapy, Doc Ophthalmol, 90, 1, 10.1007/BF01203288 Lass, 1982, Topical corticosteroid therapy for corneal toxicity from systemically administered cytarabine, Am J Ophthalmol, 94, 617, 10.1016/0002-9394(82)90006-X Albert, 1967, Ocular complications of vincristine therapy, Arch Ophthalmol, 78, 709, 10.1001/archopht.1967.00980030711004 Seidman, 1994, Photopsia during 3-hour paclitaxel administration at doses > or = 250mg/m2, J Clin Oncol, 12, 1741, 10.1200/JCO.1994.12.8.1741 Esmaeli, 2001, Canalicular stenosis secondary to docetaxel (Taxotere). A newly recognized side effect, Ophthalmology, 108, 994, 10.1016/S0161-6420(00)00640-0 Teitelbaum, 2003, Cystic maculopathy with normal capillary permeability secondary to docetaxel, Optom Vis Sci, 80, 227, 10.1097/00006324-200304000-00004 Joshi, 2007, Paclitaxel maculopathy, Arch Ophthalmol, 125, 709, 10.1001/archopht.125.5.709 Kawano, 1996, Retinal complications during interferon therapy for chronic hepatitis C, Am J Gastroenterol, 91, 309 Purvin, 1995, Anterior ischemic optic neuropathy secondary to interferon alfa, Arch Ophthalmol, 113, 1041, 10.1001/archopht.1995.01100080093034 Tang, 1995, Interferon: friend or foe?, Arch Ophthalmol, 113, 987, 10.1001/archopht.1995.01100080037026 Esmaeli, 2001, Interferon-induced retinopathy in asymptomatic cancer patients, Ophthalmology, 108, 858, 10.1016/S0161-6420(01)00546-2 Paganini-Hill, 2000, Eye problems in breast cancer patients treated with tamoxifen, Breast Cancer Res Treat, 60, 167, 10.1023/A:1006342300291 Pavlidis, 1992, Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity: a prospective study of 63 patients, Cancer, 69, 2961, 10.1002/1097-0142(19920615)69:12<2961::AID-CNCR2820691215>3.0.CO;2-W Vogel, 2006, Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial, JAMA, 295, 2727, 10.1001/jama.295.23.joc60074 Kwok, 1997, Ocular-hypertensive response to topical steroids in children, Ophthalmology, 104, 2112, 10.1016/S0161-6420(97)30052-9 Meredith, 1978, Progressive chorioretinopathy after receiving thioridazine, Arch Ophthalmol, 96, 1172, 10.1001/archopht.1978.03910060006002 Hagopian, 1966, Five cases of pigmentary retinopathy associated with thioridazine administration, Am J Psychiatry, 123, 97, 10.1176/ajp.123.1.97 Mäntyjärvi, 1998, Ocular side effects of amiodarone, Surv Ophthalmol, 42, 360, 10.1016/S0039-6257(97)00118-5 Younge, 2007, Amiodarone and ischemic optic neuropathy, J Neuroophthalmol, 27, 85, 10.1097/WNO.0b013e3180334a06 Nagra, 2003, Amiodarone induced optic neuropathy, Br J Ophthalmol, 87, 420, 10.1136/bjo.87.4.420 Purvin, 2006, Optic neuropathy in patients using amiodarone, Arch Ophthalmol, 124, 696, 10.1001/archopht.124.5.696 Blomquist, 2000, Screening for hydroxychloroquine retinopathy, Comp Ophthalmol Update, 1, 245 Marmor, 2002, Recommendations on screening for chloroquine and hydroxychloroquine retinopathy. A report by the American Academy of Ophthalmology, Ophthalmology, 109, 1377, 10.1016/S0161-6420(02)01168-5 American Academy of Ophthalmology, 2005 Sadun, 2008, Ethambutol optic neuropathy: how we can prevent 100,000 new cases of blindness each year, J Neuroophthalmol, 28, 1, 10.1097/WNO.0b013e31818f138f Kline, 2005 Laties, 1991, Expanded Clinical Evaluation of Lovastatin (EXCEL) Study results II. Assessment of the human lens after 48 weeks of treatment with lovastatin, Am J Cardiology, 67, 447, 10.1016/0002-9149(91)90002-3 Fraunfelder, 2008, Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use, Ophthalmology, 115, 2282, 10.1016/j.ophtha.2008.08.006 Millay, 1988, Niacin maculopathy, Ophthalmology, 95, 930, 10.1016/S0161-6420(88)33073-3 Hughes, 1990, Trazadone-induced palinopsia, Arch Ophthamol, 108, 399, 10.1001/archopht.1990.01070050097040 Purvin, 1995, Visual disturbance secondary to clomiphene citrate, Arch Ophthalmol, 113, 482, 10.1001/archopht.1995.01100040102034 Fraunfelder, 2009, Diplopia and fluoroquinolones, Ophthalmology, 116, 1814, 10.1016/j.ophtha.2009.06.027 Jeng, 2008, Amantadine-associated corneal edema. Potentially irreversible even after cessation of the medication, Ophthalmology, 115, 1540, 10.1016/j.ophtha.2008.03.011 Ambrosius, 2010, Lack of association between thiazolidinediones and macular edema in type 2 diabetics. The ACCORD Eye Substudy, Arch Ophthalmol, 128, 312, 10.1001/archophthalmol.2009.310 Tasman, 2007, AJO History of Ophthalmology Series. Bilberry and the Royal Air Force, Am J Ophthalmol, 144, 556, 10.1016/S0002-9394(07)00826-4 Schey, 2000, Photooxidation of lens alpha-crystallin by hypericin (active ingredient in St. John’s Wort), Photochem Photobiol, 72, 200, 10.1562/0031-8655(2000)072<0200:POLCBH>2.0.CO;2 Booth, 2009, The association between self-reported cataracts and St. John’s Wort, Curr Eye Res, 34, 863, 10.3109/02713680903144692 Fraunfelder, 2004, Ocular side effects from herbal medicines and nutritional supplements, Am J Ophthalmol, 138, 639, 10.1016/j.ajo.2004.04.072